BSE Live
Oct 16, 16:01Prev. Close
35.79
Open Price
36.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
Balance Sheet of Shukra Pharmaceuticals (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 1.57 | 1.57 | 1.57 | 1.57 | 1.57 | |
Total Share Capital | 1.57 | 1.57 | 1.57 | 1.57 | 1.57 | |
Reserves and Surplus | 13.85 | 13.81 | 13.44 | 13.01 | 12.51 | |
Total Reserves and Surplus | 13.85 | 13.81 | 13.44 | 13.01 | 12.51 | |
Total Shareholders Funds | 15.41 | 15.38 | 15.01 | 14.58 | 14.07 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 8.05 | 6.06 | 3.58 | 0.04 | 0.04 | |
Deferred Tax Liabilities [Net] | 3.10 | 2.96 | 2.85 | 2.60 | 2.44 | |
Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Non-Current Liabilities | 11.15 | 9.02 | 6.43 | 2.64 | 2.48 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade Payables | 6.46 | 3.15 | 1.93 | 1.14 | 0.52 | |
Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Short Term Provisions | 0.52 | 0.85 | 0.73 | 0.58 | 0.21 | |
Total Current Liabilities | 6.99 | 4.00 | 2.66 | 1.72 | 0.73 | |
Total Capital And Liabilities | 33.55 | 28.39 | 24.10 | 18.94 | 17.28 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 17.38 | 15.60 | 14.12 | 10.17 | 9.67 | |
Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Work-In-Progress | 1.66 | 1.66 | 1.66 | 1.64 | 1.68 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 19.04 | 17.27 | 15.78 | 11.81 | 11.36 | |
Non-Current Investments | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Non-Current Assets | 19.09 | 17.32 | 15.83 | 11.86 | 11.40 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Inventories | 1.39 | 0.27 | 0.14 | 0.32 | 0.44 | |
Trade Receivables | 7.95 | 5.35 | 2.93 | 2.47 | 0.94 | |
Cash And Cash Equivalents | 0.13 | 0.25 | 0.06 | 0.52 | 1.74 | |
Short Term Loans And Advances | 4.74 | 4.89 | 4.93 | 3.72 | 2.72 | |
OtherCurrentAssets | 0.25 | 0.32 | 0.21 | 0.05 | 0.04 | |
Total Current Assets | 14.45 | 11.07 | 8.27 | 7.08 | 5.88 | |
Total Assets | 33.55 | 28.39 | 24.10 | 18.94 | 17.28 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 1.96 | 0.06 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | 0.06 | -- | |
Other Earnings | 0.00 | -- | -- | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
12.06.2025
Shukra Pharma Standalone March 2025 Net Sales at Rs 13.27 crore, up 21.92% Y-o-Y
26.11.2024
Shukra Pharma Standalone September 2024 Net Sales at Rs 5.56 crore, down 77.45% Y-o-Y
13.08.2024
Shukra Pharma Standalone June 2024 Net Sales at Rs 3.18 crore, down 84.24% Y-o-Y
07.06.2024
Shukra Pharma Standalone March 2024 Net Sales at Rs 10.88 crore, down 76.47% Y-o-Y